Igor Rongel
About Igor Rongel
Igor Rongel serves as the Head of Investments at C6 Bank in São Paulo, Brazil, a position he has held since 2020. With a strong background in strategic planning and negotiation, he has previously worked in various leadership roles across several companies in the finance and marketing sectors.
Work at C6 Bank
Igor Rongel has been serving as the Head of Investments at C6 Bank since 2020. His tenure in this role spans four years, during which he has focused on leading investment strategies. Prior to this position, he worked at C6 Bank as Head of Investments and Loyalty for five months in 2020 and as Head of Loyalty from 2018 to 2020. His experience at C6 Bank has contributed to his expertise in negotiation and market planning.
Education and Expertise
Igor Rongel studied at UFRJ - Universidade Federal do Rio de Janeiro, where he earned a degree in Statistics. He also holds a Master of Business Administration (MBA) in Finance from Ibmec. Additionally, he has been studying at the Massachusetts Institute of Technology - Sloan School of Management, participating in the Global Executive Academy since 2018. His educational background supports his strong expertise in strategic planning, business planning, and investment management.
Background
Igor Rongel has a diverse professional background, having worked in various roles across multiple organizations. He served as Diretor Comercial e Operações at ADVISIO SOLUÇÕES EM SAÚDE from 2016 to 2018 and as Diretor Executivo de Operações at Brasil Pharma from 2015 to 2016. His earlier career includes positions such as Marketing Manager at GVT and Gerente Geral at Farmais Franchising. His extensive experience in marketing management enhances his ability to align investment strategies with market trends.
Achievements
Throughout his career, Igor Rongel has held several key positions that reflect his leadership capabilities. He worked at Oi/Telemar as Gerente Segmento B2C - Retenção e Rentabilização for seven years, contributing to customer retention and profitability strategies. His roles at Brasil Pharma, both as Diretor Comercial and Diretor Executivo de Operações, highlight his operational leadership. His comprehensive understanding of market dynamics has been instrumental in his investment management efforts.